
Sygnia Uncovers Active Chinese-Nexus Threat Actor Targeting Critical Infrastructure
Since early 2025, Sygnia has tracked and responded to Fire Ant incidents, primarily targeting VMware ESXi and vCenter environments, as well as network appliances, to establish a foothold for initial access and long-term advanced persistence. Notably, Fire Ant displays high levels of resilience, actively and stealthily adapting to eradication and containment efforts, replacing toolsets, deploying redundant persistence backdoors and manipulating network configurations to re-establish access to compromised devices.
'Fire Ant shows incredible advanced capabilities to infiltrate and conduct espionage campaigns, avoiding detection and multi-layered traditional security measures by targeting infrastructure blind spots. This highlights the level of resilience and danger posed by nation-state threat actors to global critical infrastructure organisations,' said Yoav Mazor, Head of Incident Response, APJ at Sygnia. 'By gaining control over the virtualization management layer, the threat actor was able to extract service account credentials and deploy persistent backdoors on both ESXi hosts and the vCenter to maintain access across reboots.'
Fire Ant's activities are characterized by infrastructure-centric tactics, techniques and procedures (TTPs) enabling activity beneath the detection threshold of traditional endpoint controls, emphasizing critical blind spots of conventional security stacks. The threat actor establishes control over a victim's VMware ESXi hosts and vCenter servers to move laterally across an organization. Additionally, Fire Ant consistently bypassed network segmentation by compromising network appliances and tunneling across segments, enabling the threat actor to bridge and move deeper within an organization's infrastructure through legitimate, approved paths.
Mazor adds, 'Fire Ant's method of infiltration places heightened pressure on the cybersecurity community and underscores the importance of visibility and detection within the hypervisor and infrastructure layer where traditional endpoint security tools often struggle to identify malicious activity. Organizations will need to adopt proactive cyber resilience with an advanced multi-layered security approach.'
As part of Sygnia's investigation into Fire Ant, the company found the tooling and techniques closely align with prior espionage campaigns conducted by nation-state threat actor, UNC3886, currently active in Singapore. Fire Ant's overlap with UNC3886 includes specific binaries and exploitation of vCenter and ESXi vulnerabilities, as well as similar targeting of critical infrastructure across regions.
For a deep dive account of the incident, please see Sygnia's report.
About Sygnia
Sygnia is the world's foremost cyber response and readiness expert. It applies creative approaches and bold solutions to each phase of an organization's security journey, meeting them where they are to ensure cyber resilience. Sygnia is the trusted advisor and service provider of leading organizations worldwide, including Fortune 100 companies. Sygnia is a Temasek company, part of the ISTARI Collective.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
24 minutes ago
- Business Wire
Prodapt Announces Strategic Expansion in Alberta Through Partnership with Invest Alberta
DALLAS & CHENNAI, India--(BUSINESS WIRE)--Prodapt, a global leader in telecom-native services and AI-driven transformation, has signed a Memorandum of Understanding (MOU) with Invest Alberta to expand its operations in the province. This strategic partnership marks a significant step in Prodapt's North America growth strategy, with plans to deliver more than $100 million in economic impact in Alberta over five years. 'Invest Alberta's collaboration with Prodapt represents another step toward making Alberta a hub for innovation in AI and technology investments in Alberta. Their confidence in what Alberta has to offer is an indication that our province is going in the right direction in growing a cutting-edge tech ecosystem that signals to the world that we are ready for this kind of expansion. Prodapt's trust and collaboration help bring Alberta to the world, and equip our investors to develop global solutions based on AI technology,' says Rick Christiaanse, CEO of Invest Alberta. Prodapt's expansion includes establishing a nearshore delivery center to serve North American clients, with a focus on AI, cloud, and digital transformation. The company will collaborate with Alberta's leading universities to develop AI consulting and advisory services, specializing in Sovereign AI, GenAI platforms, and next-generation software engineering. 'This expansion represents more than just growth — it's a commitment to building lasting partnerships in one of North America's most ambitious innovation ecosystems,' said Manish Vyas, CEO of Prodapt. 'We're excited to collaborate with government, academia, and local businesses to advance the future of technology and deliver meaningful impact across Alberta.' Accelerating Digital Transformation in Western Canada Rajiv Papneja, Chief Technology Officer at Prodapt, noted: 'Alberta serves as a catalyst for our vision around Sovereign AI and next-gen platform engineering. With strong university ecosystems and a government focused on digital innovation, we're positioned to co-create solutions in AI, automation, and cloud that will benefit both Canada and global markets.' This initiative supports Alberta's strategic shift toward technology, clean energy, and AI-driven innovation, creating high-value opportunities for local talent and businesses. The university collaboration will include co-creating AI programs, offering real-world consulting projects, and developing a skilled workforce for tech roles. Strengthening Local Talent and Innovation The partnership strengthens Alberta's innovation landscape while positioning the province as a competitive destination for global technology investment. 'The support from Invest Alberta underscores our shared belief in Alberta's potential as a technology and talent hub. This MOU lays the foundation for a nearshore delivery center that will serve our North American clients, while fostering innovation through close collaboration with local universities and government programs,' said Sricharan Kuppam, Canada country head, Prodapt. 'As the province's engine for innovation, Alberta Innovates sees this MOU between Invest Alberta and Prodapt, as a big step forward for growing tech in Alberta,' says Mike Mahon, CEO Alberta Innovates. 'International partnerships like these are the key to diversifying and growing our economy. We couldn't be happier to welcome Prodapt to the ecosystem.' About Prodapt Prodapt is the largest specialized player in the Connectedness industry. As an AI-first strategic technology partner, Prodapt provides consulting, business reengineering, and managed services for the largest telecom and tech enterprises building networks and digital experiences of tomorrow. A ServiceNow-invested company, Prodapt has been recognized by Gartner as a Large, Telecom-Native, Regional IT Service Provider. Connecting 1.1 billion people and 5.4 billion devices across the globe, Prodapt's clients include Rogers, Telus, Verizon, Vodafone, Liberty Global, Liberty Latin America, Claro, Lumen, Windstream, KPN, Virgin Media, British Telecom, Deutsche Telekom, Google, Amazon, PayPal, SoftBank, ServiceNow, Ciena, Adtran, Samsung and many more. A 'Great Place To Work® Certified™' company, Prodapt employs over 6,000 technology and domain experts across the Americas, Europe, India, Africa, & Japan. Prodapt is part of the 130-year-old business conglomerate The Jhaver Group, which employs over 32,000 people across 80+ locations globally.


Business Upturn
25 minutes ago
- Business Upturn
Takeda Announces First-Quarter FY2025 Results With Significant Late-Stage Pipeline Progression
Business Wire India Revenue Decline of 3.7% at Constant Exchange Rate (CER); 8.4% Decline at Actual Exchange Rates (AER) as VYVANSE®Generic Erosion Impacts Revenue in Line With Company Expectations Core Operating Profit Decline of 11.9% at CER, Primarily Reflecting Generic Erosion Reported Operating Profit Increase of 11.0% at AER, Reflecting Lower YoY Impairment and Restructuring Expenses Positive Results from Two Pivotal Phase 3 Studies of Oveporexton in Narcolepsy Type 1 Reinforce Continued Momentum in Late-Stage Pipeline No Change to Full-Year Outlook Announced in May Takeda (TOKYO:4502/NYSE:TAK) today announced earnings results for the first quarter of fiscal year 2025 (three months ended June 30, 2025), with generic erosion of VYVANSE significantly impacting revenue and Core Operating Profit in line with company expectations for the quarter. The company expects these impacts to moderate in future quarters. Takeda also achieved several important milestones in its R&D pipeline, reinforcing its long-term growth trajectory and underscoring its commitment to delivering sustainable value through innovation. Most notably, both Phase 3 studies of oveporexton successfully met all primary and secondary endpoints, demonstrating statistically significant improvements across doses. These results reinforce the potential of oveporexton to transform the standard of care in narcolepsy type 1. In addition, Takeda received U.S. FDA approval for GAMMAGARD® LIQUID ERC and European Commission (EC) approval for ADCETRIS® in new indications and presented promising clinical data for rusfertide at the 61st American Society of Clinical Oncology (ASCO) Annual Meeting Plenary Session. These developments underscore the strength of Takeda's late-stage pipeline and its potential to drive future growth. Takeda chief financial officer, Milano Furuta, commented: 'The impact of VYVANSE generic erosion on Takeda's FY2025 Q1 results was very significant, but consistent with our expectations, and there is no change to our full-year outlook announced in May. 'Our late-stage pipeline continues to advance with the announcement in July of positive results from two pivotal Phase 3 studies for oveporexton in narcolepsy type 1, with both studies meeting all primary and secondary endpoints. These results represent a significant scientific milestone, and we are very excited about the potential for our late-stage pipeline to deliver value to the patients we serve and to position Takeda for sustainable growth.' FINANCIAL HIGHLIGHTS for FY2025 Q1 Ended June 30, 2025 (Billion yen, except percentages and per share amounts) FY2025 Q1 FY2024 Q1 vs. PRIOR YEAR (Actual % change) Revenue 1,106.7 1,208.0 -8.4% Operating Profit 184.6 166.3 +11.0% Net Profit 124.2 95.2 +30.4% EPS (Yen) 79 61 +30.8% Operating Cash Flow 215.4 170.3 +26.5% Adjusted Free Cash Flow (Non-IFRS) 190.1 23.7 +703.6% Core (Non-IFRS) (Billion yen, except percentages and per share amounts) FY2025 Q1 FY2024 Q1 vs. PRIOR YEAR (Actual % change) vs. PRIOR YEAR (CER % change) Revenue 1,106.7 1,208.0 -8.4% -3.7% Operating Profit 321.8 382.3 -15.8 % -11.9% Margin 29.1% 31.6% -2.6 pp ― Net Profit 237.0 276.8 -14.4% -10.3% EPS (Yen) 151 176 -14.1% -10.0% FY2025 Outlook (unchanged from May 2025) (Billion yen, except percentages and per share amounts) FY2025 FORECAST FY2025 MANAGEMENT GUIDANCE Core Change at CER (Non-IFRS) Revenue 4,530.0 — Core Revenue (Non-IFRS) 4,530.0 Broadly flat Operating Profit 475.0 — Core Operating Profit (Non-IFRS) 1,140.0 Broadly flat Net Profit 228.0 — EPS (Yen) 145 — Core EPS (Yen) (Non-IFRS) 485 Broadly flat Adjusted Free Cash Flow (Non-IFRS) 750.0-850.0 — Annual Dividend per Share (Yen) 200 — Additional Information About Takeda's FY2025 Q1 Results For more details about Takeda's FY2025 Q1 results, commercial progress, pipeline updates and other financial information, including key assumptions in the FY2025 forecast and management guidance as well as definitions of non-IFRS measures, please refer to Takeda's FY2025 Q1 investor presentation (available at About Takeda Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit Important Notice For the purposes of this notice, 'press release' means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited ('Takeda') regarding this press release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws. The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, 'Takeda' is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words 'we', 'us' and 'our' are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies. The product names appearing in this document are trademarks or registered trademarks owned by Takeda, or their respective owners. Forward-Looking Statements This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda's future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as 'targets', 'plans', 'believes', 'hopes', 'continues', 'expects', 'aims', 'intends', 'ensures', 'will', 'may', 'should', 'would', 'could', 'anticipates', 'estimates', 'projects', 'forecasts', 'outlook' or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda's global business, including general economic conditions in Japan and the United States and with respect to international trade relations; competitive pressures and developments; changes to applicable laws and regulations, including tax, tariff and other trade-related rules; challenges inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic; the success of our environmental sustainability efforts, in enabling us to reduce our greenhouse gas emissions or meet our other environmental goals; the extent to which our efforts to increase efficiency, productivity or cost-savings, such as the integration of digital technologies, including artificial intelligence, in our business or other initiatives to restructure our operations will lead to the expected benefits; and other factors identified in Takeda's most recent Annual Report on Form 20-F and Takeda's other reports filed with the U.S. Securities and Exchange Commission, available on Takeda's website at: at does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda's future results. Financial information and Non-IFRS Measures Takeda's financial statements are prepared in accordance with International Financial Reporting Standards ('IFRS'). This press release and materials distributed in connection with this press release include certain financial measures not presented in accordance with IFRS, such as Core Revenue, Core Operating Profit, Core Net Profit for the year attributable to owners of the Company, Core EPS, Constant Exchange Rate ('CER') change, Net Debt, Adjusted Net Debt, EBITDA, Adjusted EBITDA, Free Cash Flow and Adjusted Free Cash Flow. Takeda's management evaluates results and makes operating and investment decisions using both IFRS and non-IFRS measures included in this press release. These non-IFRS measures exclude certain income, cost and cash flow items which are included in, or are calculated differently from, the most closely comparable measures presented in accordance with IFRS. Takeda's non-IFRS measures are not prepared in accordance with IFRS and such non-IFRS measures should be considered a supplement to, and not a substitute for, measures prepared in accordance with IFRS (which we sometimes refer to as 'reported' measures). Investors are encouraged to review the definitions and reconciliations of non-IFRS measures to their most directly comparable IFRS measures, which are in the Financial Appendix appearing at the end of our FY2025 Q1 investor presentation (available at Peak Sales and PTRS Estimates References in this press release to peak revenue potential ranges are estimates that have not been adjusted for probability of technical and regulatory success (PTRS) and should not be considered a forecast or target. These peak revenue potential ranges represent Takeda's assessments of various possible future commercial scenarios that may or may not occur. References in this press release to PTRS are to internal estimates of Takeda regarding the likelihood of obtaining regulatory approval for a particular product in a particular indication. These estimates reflect the subjective judgment of responsible Takeda personnel and have been approved by Takeda's Portfolio Review Committee for use in internal planning. Medical information This press release contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, in different dosages, or in different strengths. Nothing contained herein should be considered a solicitation, promotion or advertisement for any prescription drugs including the ones under development. Please refer to slide 6 of Takeda's FY2025 Q1 investor presentation (available at for the definition of Growth & Launch Products. View source version on Disclaimer: The above press release comes to you under an arrangement with Business Wire India. Business Upturn take no editorial responsibility for the same. Ahmedabad Plane Crash
Yahoo
43 minutes ago
- Yahoo
UBS reports 2Q25 net profit of USD 2.4bn and USD 4.1bn for 1H25 with integration remaining on track; invested assets reach USD 6.6trn (Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules)
ZURICH, July 30, 2025--(BUSINESS WIRE)--Regulatory News: UBS (NYSE:UBS) (SWX:UBSN): "We sustained robust momentum during a quarter that started with extreme volatility by staying close to our clients and executing on our integration plans. We also maintained a balance sheet for all seasons while delivering on our capital return plans. We are positioning for long term success by further enhancing our global capabilities, investing in our future infrastructure and AI, while actively engaging in the debate on future regulation in Switzerland. This allows us to fulfill our commitment to support all the communities where we live and work." Sergio P. Ermotti, Group CEO 2Q25 PBT of USD 2.2bn and underlying1 PBT of USD 2.7bn, net profit of USD 2.4bn, RoCET1 of 13.5% and underlying RoCET1 of 15.3%. Core businesses2 increased combined underlying PBT by 25% YoY 1H25 PBT of USD 4.3bn and underlying PBT of USD 5.3bn, net profit of USD 4.1bn, RoCET1 of 11.6% and underlying RoCET1 of 13.3% Continued client momentum in a volatile environment supporting growth in Group invested assets, with Global Wealth Management 1H25 net new assets of USD 54.8bn. GWM 2Q25 transaction-based income +12% YoY and best second quarter in Global Markets with revenues up 25% YoY supported by record balances and revenues in Prime Brokerage Integration remains on track with one-third of client accounts booked in Switzerland migrated. Delivered further USD 0.7bn in exit rate gross cost saves bringing cumulative cost reductions to USD 9.1bn, or 70% of the USD ~13bn in expected gross saves Continued progress in Non-core and Legacy wind-down and legal entity structure simplification; NCL risk- weighted assets down by USD 1.5bn sequentially to USD 32.7bn Maintained strong capital position with 14.4% CET1 capital ratio and 4.4% CET1 leverage ratio. Our ability to generate capital is funding strategic investments and sustainable shareholder returns Delivering on our capital return plans for 2025, completed USD 0.5bn in share buybacks and plan to complete repurchase of up to USD 2.0bn in the second half of the year. Continued accruing for a double-digit growth in dividend Reliable partner for the Swiss economy, staying close to private clients and businesses with our balance sheet for all seasons and leading credit offering. Granted or renewed around CHF 40bn of loans during the quarter Positioning for long-term success by strengthening global capabilities and investing into future-ready infrastructure and tools, including Gen AI and cloud to enable secure, scalable delivery and boosting productivity. Meanwhile, actively engaging in debate on future regulatory requirements in Switzerland USD 2.2bn Profit before tax 80.5% Cost/income ratio 13.5% RoCET1 capital USD 2.4bn Net profit 14.4% CET1 capital ratio USD 2.7bn Underlying1profit before tax 75.4% Underlying1cost/income ratio 15.3% Underlying1RoCET1 capital USD 0.72 Diluted EPS 4.4% CET1 leverage ratio Information in this news release is presented for UBS Group AG on a consolidated basis unless otherwise specified. 1 Underlying results exclude items of profit or loss that management believes are not representative of the underlying performance. Underlying results are a non-GAAP financial measure and alternative performance measure (APM). Refer to "Group Performance" and "Appendix-Alternative Performance Measures" in the financial report for the second quarter of 2025 for a reconciliation of underlying to reported results and definitions of the APMs. 2 Includes Global Wealth Management, Personal & Corporate Banking, Asset Management, the Investment Bank, and Group Items. Group summary Strong financial performance In 2Q25, we reported PBT of USD 2,193m and underlying PBT of USD 2,683m, up 49% and 30% YoY, respectively, driven by growth in our core businesses, which increased their combined underlying pre-tax profits by 25% YoY. Net profit attributable to shareholders was USD 2,395m, up 111% YoY and included a net release of provisions and contingent liabilities of USD 427m related to the resolution of a legacy Credit Suisse cross-border matter and a net deferred tax benefit of USD 577m. Return on CET1 capital was 13.5%, or 15.3% on an underlying basis. Reported revenues were USD 12,112m, up 2% YoY. On an underlying basis, revenues increased by 4% to USD 11,546m. Underlying revenues from our core businesses increased 8%, reflecting the strength, scale and geographic diversification of our franchises and our ability to drive synergies across the Group. Underlying revenues in Non-core and Legacy division declined by USD 484m from 2Q24, mainly reflecting lower net gains on position exits as we significantly reduced NCL's portfolio through successful de-risking actions over the last year. Reported Group operating expenses decreased by 6% YoY to USD 9,756m. On an underlying basis, operating expenses decreased by 3% to USD 8,701m as we continued to execute on our integration and efficiency plans at pace. For the first half of 2025, we reported PBT of USD 4,325m and underlying PBT of USD 5,269m, driven by a 2% increase in underlying revenues and a 2% decline in underlying expenses. Net profit increased to USD 4,087m, with RoCET1 of 11.6% and underlying RoCET1 of 13.3%. Continued client momentum During the second quarter, clients continued to rely on UBS, valuing the breadth of our advice and global capabilities amid a challenging and unpredictable geopolitical and market environment. Group invested assets reached USD 6.6trn, up 8% QoQ driven by increases across Global Wealth Management, Asset Management and Personal & Corporate Banking. In GWM net new assets reached USD 23bn with strong generation in APAC, EMEA and Switzerland and robust performance in the Americas, where high inflows from existing clients mostly offset outflows from seasonal tax-related payments. Transactional activity during the quarter remained robust despite more muted sentiment among private clients, while institutional clients remained very active. In GWM, transaction-based income increased by 12% YoY with positive momentum across all regions. In the Investment Bank, Global Markets delivered a record second quarter with revenues of USD 2.3bn, up 25% YoY, tracking the exceptional levels of volatility early in the quarter. Higher revenues in Equities and FX once again reflect our ability to serve clients in a dynamic market environment, capturing growth opportunities in the areas of our strategic focus. Reliable partner for the Swiss economy Businesses and households in Switzerland benefit from our global reach, advice and expertise. Our balance sheet for all seasons gives them the stability they need while allowing us to remain a leading provider of credit to the economy. We have granted or renewed around CHF 40bn of loans during the quarter. Our conservative approach to risk and highly robust business model is reflected in the Group's loan-to-deposit ratio of 81% and cost of risk of only 10bps. Integration on track with strong progress on client account migrations in Switzerland We progressed our integration plans at pace during the quarter. We have now completed the migration of Credit Suisse client accounts booked outside of Switzerland to the UBS platform and executed the first main wave of migrations in Switzerland, having now transferred approximately one-third of targeted client accounts. We remain on track to complete the Swiss booking center migrations by the end of the first quarter of 2026. Additionally, we have made substantial progress on the simplification of our legal entity structure in the US and Europe in the quarter. Delivering on cost savings plans Through disciplined execution of our cost-reduction work we delivered an additional USD 0.7bn in gross cost saves in the quarter by further downsizing Non-core and Legacy's expense base and realizing cost synergies in the core businesses. To date we have decommissioned around 700 applications, or 56% of NCL's initial stack. We have already achieved 70% of our plan and are well on track to deliver around USD 13bn in Group-wide annualized exit rate gross cost savings by end-2026. As in previous quarters, we continued to exit positions in NCL leading to a USD 1.5bn RWA reduction in 2Q25 and bringing RWA to USD 32.7bn at the end of June. With 83% of its initial books closed, NCL remains on track to achieve its ambition to close over 95% of them by end-2026 and reduce RWA below USD 22bn. Maintained strong capital position In the second quarter, we maintained a strong capital position with a CET1 capital ratio of 14.4% and a CET1 leverage ratio of 4.4%. Both are in excess of our guidance of ~14% and >4.0%, respectively, and provide a solid capital buffer to requirements during the integration, while allowing us to self-fund strategic investments and return capital to shareholders. Commitment to capital returns In the second quarter, we continued to accrue for a double-digit increase in the ordinary dividend per share, to be paid out in 2026 and completed USD 0.5bn in share repurchases. In the first half of 2025 we have completed USD 1bn in share repurchases and plan to complete repurchase of up to USD 2bn in the second half of 2025. This plan continues to be subject to UBS maintaining a CET1 capital ratio target of around 14% and achieving its financial targets and is consistent with UBS's previously communicated plans and conservative approach. We will communicate on our 2026 capital returns ambitions with our fourth quarter and full-year financial results for 2025. Investing for long-term growth We remain focused on strengthening our global capabilities by investing into our businesses and technology to capture long-term growth opportunities. We are also well underway on our technology integration journey in 2025, reducing complexity and costs through infrastructure and application decommissioning. With 1,154 apps decommissioned to date, or ~40% of total in scope, we have surpassed the 1,000 business applications decommissioned milestone. We have also turned off over half of the servers in scope (60,000) and worked through 28PB of data. We are unlocking the transformational potential of Gen AI. In the second quarter, we have further rolled out AI-powered tools to employees, including coding tools for our developers to enable faster, more secure and scalable delivery of solutions with a targeted 15% efficiency gain. After finishing the implementation of 55,000 M365 Copilot licenses earlier this year we are planning to roll-out additional licenses to ensure all of our employees across the firm have access to the tool. Additionally, our in-house AI assistant, Red, which gives users intelligent access to UBS products, research, and CIO reports, is currently rolled out to 52,000 employees with general availability planned for the first half of 2026. Our investments in this space continue to translate into increased usage of Gen AI tools across the organization with 8m prompts across all our tools in the quarter, a four-fold increase since year-end 2024. We are also progressing on the execution of our large-scale, transformational AI initiatives designed to have firm-wide impact and strengthen our foundations, enhancing client service and increasing productivity across the Group. In addition, we are continually assessing and building further opportunities with over 280 AI use cases now live, up ~10% from 1Q25. To support in the adoption of our AI capabilities and foster a culture of continuous learning across the organization, we are building a strong ecosystem across the firm including over 500 AI Champions and 100 AI Ambassadors. Later this year around 250 of our senior leaders, including the Group Executive Board, will participate in an AI Senior Leadership Journey at the Saïd Business School, University of Oxford. The program will focus on building an AI-enabled organization, driving transformation, and ensuring ethical governance. This initiative is designed to equip our leaders with the strategic insights needed to further embed AI across the firm and lead the development of an AI-enabled workforce. Outlook The third quarter started with strong market performance in risk assets, particularly international equities, combined with a weak US dollar. Investor sentiment remains broadly constructive, tempered by persistent macroeconomic and geopolitical uncertainties. Against this backdrop, our client conversations and deal pipelines indicate a high level of readiness among investors and corporates to deploy capital, as conviction around the macro outlook strengthens. For the third quarter, we expect Global Wealth Management's net interest income (NII) and Personal & Corporate Banking's NII in Swiss francs to be broadly stable. In US dollar terms, this translates to a sequential low single-digit percentage increase. We also expect trading and transactional activity to reflect more normalized seasonal patterns and activity levels compared to the same quarter a year ago, particularly in Global Wealth Management's transaction-based revenues and the Investment Bank's Global Markets performance. Pull-to-par revenues3 are expected to be around USD 0.4bn, partly mitigating the expected USD 1.1bn in integration-related expenses. We remain focused on actively engaging with our clients, helping them to navigate a complex environment while executing on our growth and integration plans. We are confident in our ability to deliver on our 2025 and 2026 financial targets, leveraging the power of our diversified business model. 3 Pull-to-par revenues are revenues recognized when fair value reductions taken on financial instruments acquired as part of the Credit Suisse transaction through the required purchase price allocation (PPA) unwind as the instruments approach their maturity. Second quarter 2025 performance overview – Group Group PBT USD 2,193m, underlying PBT USD 2,683m PBT of USD 2,193m included PPA effects and other integration items of USD 596m, a loss related to an investment in an associate of USD 31m, and integration-related expenses and PPA effects of USD 1,055m. Underlying PBT was USD 2,683m, including net credit loss expenses of USD 163m. The cost/income ratio was 80.5%, and 75.4% on an underlying basis. Net profit attributable to shareholders was USD 2,395m, with diluted earnings per share of USD 0.72. Return on CET1 capital was 13.5%, and 15.3% on an underlying basis. Global Wealth Management (GWM) PBT USD 1,204m, underlying PBT USD 1,443m Total revenues increased by USD 247m, or 4%, to USD 6,300m, largely driven by higher recurring net fee income and transaction-based income, partly offset by lower net interest income, and included a USD 80m decrease in PPA effects and other integration items. Excluding USD 153m of PPA effects and other integration items and a USD 8m loss related to an investment in an associate, underlying total revenues were USD 6,156m, an increase of 6%. Net credit loss expenses were USD 3m, compared with net credit loss releases of USD 1m in the second quarter of 2024. Operating expenses decreased by USD 90m, or 2%, to USD 5,093m and included a USD 140m decrease in integration-related expenses. Excluding USD 383m of integration-related expenses and PPA effects, underlying operating expenses were USD 4,710m, an increase of 1%, mainly driven by unfavorable foreign currency effects and higher financial advisor compensation reflecting an increase in compensable revenues. The cost/income ratio was 80.8%, and 76.5% on an underlying basis. Invested assets increased sequentially by USD 294bn to USD 4,512bn. Net new assets were USD 23bn. Personal & Corporate Banking (P&C) PBT CHF 566m, underlying PBT CHF 557m Total revenues decreased by CHF 161m, or 8%, to CHF 1,900m, mainly due to lower net interest income and other income, and included a CHF 1m decrease in PPA effects and other integration items. Total revenues in the second quarter of 2025 also included a loss of CHF 18m related to an investment in an associate. Excluding CHF 222m of PPA effects and other integration items and the aforementioned loss, underlying total revenues were CHF 1,696m, a decrease of 8%. Net credit loss expenses were CHF 91m and mainly reflected net expenses on credit-impaired positions. Net credit loss expenses in the prior-year quarter were CHF 92m. Operating expenses decreased by CHF 23m, or 2%, to CHF 1,243m and included a CHF 30m increase in integration-related expenses. Excluding CHF 195m of integration-related expenses and PPA effects, underlying operating expenses were CHF 1,048m, a decrease of 5%, mainly driven by lower personnel expenses, including lower variable compensation. The cost/income ratio was 65.4%, and 61.8% on an underlying basis. Asset Management (AM) PBT USD 153m, underlying PBT USD 216m Total revenues increased by USD 4m to USD 772m, reflecting increases in net management fees and performance fees, largely offset by the second quarter of 2024 including USD 28m of net gains from disposals. Operating expenses decreased by USD 20m, or 3%, to USD 618m and included a USD 35m decrease in integration-related expenses. Excluding integration-related expenses of USD 63m, underlying operating expenses were USD 555m, an increase of 3%, mainly due to unfavorable foreign currency effects. The cost/income ratio was 80.1%, and 72.0% on an underlying basis. Invested assets increased sequentially by USD 156bn to USD 1,952bn. Net new money was negative USD 2bn, and negative USD 5bn excluding money market flows and associates. Investment Bank (IB) PBT USD 557m, underlying PBT USD 526m Total revenues increased by USD 163m, or 6%, to USD 2,966m, due to higher revenues in Global Markets, partly offset by lower revenues in Global Banking, and included an overall USD 158m decrease in PPA effects. Excluding these effects, underlying total revenues were USD 2,815m, an increase of 13%, including positive foreign currency effects. Net credit loss expenses were USD 48m, compared with net credit loss releases of USD 6m in the second quarter of 2024. Operating expenses increased by USD 29m, or 1%, to USD 2,361m, and included a USD 124m decrease in integration-related expenses. Excluding integration-related expenses of USD 121m, underlying operating expenses were USD 2,241m, an increase of 7%, mainly due to higher personnel expenses and unfavorable foreign currency effects. The cost/income ratio was 79.6% on a reported and underlying basis. Return on attributed equity was 12.2%, and 11.5% on an underlying basis. Non-core and Legacy (NCL) PBT USD (250m), underlying PBT USD 1m Total revenues were negative USD 82m, compared with total revenues of USD 401m, mainly reflecting lower net gains from position exits and lower net interest income from securitized products and credit products, partly offset by lower liquidity and funding costs, as a result of a smaller portfolio. Net credit loss releases were USD 2m, compared with net credit loss releases of USD 1m in the second quarter of 2024. Operating expenses were USD 170m, a decrease of USD 637m, or 79%, mainly due to releases in provisions for litigation, regulatory and similar matters, as well as lower personnel expenses, risk management costs, technology costs and compliance and regulatory costs, and included a USD 73m decrease in integration-related expenses. Excluding integration-related expenses of USD 252m, underlying operating expenses were negative USD 83m. Group Items PBT USD (167m), underlying PBT USD (188m) 4 Also accounts for credit loss expenses/releases incurred in a given period. UBS's sustainability and impact highlights We support our clients in the transition to a low-carbon world and consider climate change risks and opportunities across our firm for the benefit of our clients, our shareholders and all our stakeholders. SDG Outcomes Fund hits USD 100m target with anchor commitment from the EU Earlier this month, the UBS Optimus Foundation and Bridges Outcomes Partnerships announced the successful final closing of the SDG Outcomes Fund at the 4th UN International Conference on Financing for Development (FFD4) in Seville. Through the new anchor commitment from the European Union, the fund reached its subscription target of USD 100m. This Luxembourg-based SFDR Article 9 fund is a pioneering blended finance initiative designed to accelerate progress toward the United Nations Sustainable Development Goals (SDGs) by supporting outcomes-focused programs in low- and middle-income countries, particularly in Africa and Asia. Expanded UBS Optimus Foundation offering in the US In June, we announced the expansion of the UBS Optimus Foundation offering in the US. The Foundation, a client-facing giving platform that supports clients' philanthropic goals through flexible, tax-advantaged giving solutions now provides access to an expanded portfolio of programs across the US in addition to the full portfolio of existing global programs. Clients can support a suite of national-scale programs, sourced and vetted by a team of dedicated philanthropy experts, that advance solutions across education, health, the environment, and emergency response and resilience. The UBS Optimus Foundation continues to expand its US portfolio and now has 15 nonprofit partners on the front lines of the country's most pressing challenges. UBS covers all the administrative costs of the Foundation, ensuring that 100% of each donation received supports the Foundation's programs and mission. UBS will also provide up to a 10% match on client and employee donations to incentivize giving and magnify its impact (subject to availability). Employer of choice among Swiss business students According to Universum's 2025 survey published in June, UBS is the employer of choice among business students in Switzerland. We were the top choice for one in four business students – and for the first time ever, we came first among female business students too. Selected financial information of the business divisions and Group Items For the quarter ended 30.6.25 USD m GlobalWealthManagement Personal & Corporate Banking Asset Management Investment Bank Non-coreand Legacy GroupItems Total Total revenues as reported 6,300 2,336 772 2,966 (82) (180) 12,112 of which: PPA effects and other integration items1 153 274 152 1 17 596 of which: loss related to an investment in an associate (8) (23) (31) Total revenues (underlying) 6,156 2,085 772 2,815 (83) (198) 11,546 Credit loss expense / (release) 3 114 0 48 (2) 0 163 Operating expenses as reported 5,093 1,528 618 2,361 170 (13) 9,756 of which: integration-related expenses and PPA effects2 383 240 63 121 252 (4) 1,055 Operating expenses (underlying) 4,710 1,288 555 2,241 (83) (10) 8,701 Operating profit / (loss) before tax as reported 1,204 695 153 557 (250) (167) 2,193 Operating profit / (loss) before tax (underlying) 1,443 684 216 526 1 (188) 2,683 For the quarter ended 31.3.25 USD m GlobalWealthManagement Personal & Corporate Banking Asset Management Investment Bank Non-coreand Legacy GroupItems Total Total revenues as reported 6,422 2,211 741 3,183 284 (284) 12,557 of which: PPA effects and other integration items1 165 241 138 30 574 of which: gain related to an investment in an associate 4 11 14 of which: items related to the Swisscard transactions3 64 64 Total revenues (underlying) 6,253 1,895 741 3,045 284 (314) 11,904 Credit loss expense / (release) 6 53 0 35 7 (1) 100 Operating expenses as reported 5,057 1,551 606 2,427 669 15 10,324 of which: integration-related expenses and PPA effects2 355 192 73 112 191 3 927 of which: items related to the Swisscard transactions4 180 180 Operating expenses (underlying) 4,702 1,179 533 2,314 477 12 9,218 Operating profit / (loss) before tax as reported 1,359 607 135 722 (391) (299) 2,132 Operating profit / (loss) before tax (underlying) 1,545 663 208 696 (200) (326) 2,586 For the quarter ended 30.6.24 USD m GlobalWealthManagement Personal & Corporate Banking Asset Management Investment Bank Non-coreand Legacy GroupItems Total Total revenues as reported 6,053 2,272 768 2,803 401 (392) 11,904 of which: PPA effects and other integration items1 233 246 310 (8) 780 Total revenues (underlying) 5,820 2,026 768 2,493 401 (384) 11,124 Credit loss expense / (release) (1) 103 0 (6) (1) 0 95 Operating expenses as reported 5,183 1,396 638 2,332 807 (15) 10,340 of which: integration-related expenses and PPA effects2 523 182 98 245 325 (2) 1,372 Operating expenses (underlying) 4,660 1,213 540 2,087 481 (13) 8,969 Operating profit / (loss) before tax as reported 871 773 130 477 (405) (377) 1,469 Operating profit / (loss) before tax (underlying) 1,161 710 228 412 (80) (371) 2,060 1 Includes accretion of PPA adjustments on financial instruments and other PPA effects, as well as temporary and incremental items directly related to the integration. 2 Includes temporary, incremental operating expenses directly related to the integration, as well as amortization of intangibles resulting from the acquisition of the Credit Suisse Group. 3 Represents the gain related to UBS's share of income recorded by Swisscard for the sale of the Credit Suisse card portfolios to UBS. 4 Represents the expense related to the payment to Swisscard for the sale of the Credit Suisse card portfolios to UBS. Selected financial information of the business divisions and Group Items (continued) Year-to-date 30.6.25 USD m GlobalWealthManagement Personal & Corporate Banking Asset Management Investment Bank Non-coreand Legacy GroupItems Total Total revenues as reported 12,722 4,547 1,513 6,149 202 (465) 24,668 of which: PPA effects and other integration items1 318 514 290 1 47 1,170 of which: gain / (loss) related to an investment in an associate (5) (12) (16) of which: items related to the Swisscard transactions2 64 64 Total revenues (underlying) 12,408 3,980 1,513 5,860 201 (512) 23,450 Credit loss expense / (release) 9 167 0 83 6 (1) 263 Operating expenses as reported 10,150 3,078 1,224 4,788 838 2 20,080 of which: integration-related expenses and PPA effects3 739 432 135 233 444 (1) 1,982 of which: items related to the Swisscard transactions4 180 180 Operating expenses (underlying) 9,411 2,467 1,088 4,555 395 2 17,918 Operating profit / (loss) before tax as reported 2,563 1,302 289 1,279 (642) (465) 4,325 Operating profit / (loss) before tax (underlying) 2,988 1,347 424 1,222 (199) (513) 5,269 Year-to-date 30.6.24 USD m GlobalWealthManagement Personal & Corporate Banking Asset Management Investment Bank Non-coreand Legacy GroupItems Total Total revenues as reported 12,196 4,695 1,543 5,554 1,402 (747) 24,642 of which: PPA effects and other integration items1 467 502 603 (12) 1,559 Total revenues (underlying) 11,729 4,193 1,543 4,951 1,402 (735) 23,083 Credit loss expense / (release) (4) 146 0 26 35 (2) 201 Operating expenses as reported 10,228 2,800 1,303 4,496 1,818 (48) 20,597 of which: integration-related expenses and PPA effects3 928 342 169 387 568 (1) 2,392 Operating expenses (underlying) 9,300 2,458 1,134 4,109 1,250 (47) 18,205 Operating profit / (loss) before tax as reported 1,972 1,748 241 1,032 (451) (698) 3,844 Operating profit / (loss) before tax (underlying) 2,433 1,588 410 816 117 (687) 4,677 1 Includes accretion of PPA adjustments on financial instruments and other PPA effects, as well as temporary and incremental items directly related to the integration. 2 Represents the gain related to UBS's share of income recorded by Swisscard for the sale of the Credit Suisse card portfolios to UBS. 3 Includes temporary, incremental operating expenses directly related to the integration, as well as amortization of intangibles resulting from the acquisition of the Credit Suisse Group. 4 Represents the expense related to the payment to Swisscard for the sale of the Credit Suisse card portfolios to UBS. Our key figures As of or for the quarter ended As of or year-to-date USD m, except where indicated 30.6.25 31.3.25 31.12.24 30.6.24 30.6.25 30.6.24 Group results Total revenues 12,112 12,557 11,635 11,904 24,668 24,642 Credit loss expense / (release) 163 100 229 95 263 201 Operating expenses 9,756 10,324 10,359 10,340 20,080 20,597 Operating profit / (loss) before tax 2,193 2,132 1,047 1,469 4,325 3,844 Net profit / (loss) attributable to shareholders 2,395 1,692 770 1,136 4,087 2,890 Diluted earnings per share (USD)1 0.72 0.51 0.23 0.34 1.23 0.86 Profitability and growth2,3 Return on equity (%) 10.9 7.9 3.6 5.4 9.4 6.8 Return on tangible equity (%) 11.8 8.5 3.9 5.9 10.2 7.5 Underlying return on tangible equity (%)4 13.4 10.0 6.6 8.4 11.7 9.2 Return on common equity tier 1 capital (%) 13.5 9.6 4.2 5.9 11.6 7.5 Underlying return on common equity tier 1 capital (%)4 15.3 11.3 7.2 8.4 13.3 9.2 Revenues over leverage ratio denominator, gross (%) 3.0 3.3 3.0 3.0 3.1 3.1 Cost / income ratio (%) 80.5 82.2 89.0 86.9 81.4 83.6 Underlying cost / income ratio (%)4 75.4 77.4 81.9 80.6 76.4 78.9 Effective tax rate (%) (9.5) 20.2 25.6 20.0 5.1 23.6 Net profit growth (%) 110.9 (3.6) n.m. (95.8) 41.4 (89.8) Resources2 Total assets 1,669,991 1,543,363 1,565,028 1,560,976 1,669,991 1,560,976 Equity attributable to shareholders 89,277 87,185 85,079 83,683 89,277 83,683 Common equity tier 1 capital5 72,709 69,152 71,367 76,104 72,709 76,104 Risk-weighted assets5 504,500 483,276 498,538 511,376 504,500 511,376 Common equity tier 1 capital ratio (%)5 14.4 14.3 14.3 14.9 14.4 14.9 Going concern capital ratio (%)5 18.2 18.2 17.6 18.0 18.2 18.0 Total loss-absorbing capacity ratio (%)5 37.9 38.7 37.2 38.7 37.9 38.7 Leverage ratio denominator5 1,658,089 1,561,583 1,519,477 1,564,201 1,658,089 1,564,201 Common equity tier 1 leverage ratio (%)5 4.4 4.4 4.7 4.9 4.4 4.9 Liquidity coverage ratio (%)6 182.3 181.0 188.4 212.0 182.3 212.0 Net stable funding ratio (%) 122.4 124.2 125.5 128.0 122.4 128.0 Other Invested assets (USD bn)3,7 6,618 6,153 6,087 5,873 6,618 5,873 Personnel (full-time equivalents) 105,132 106,789 108,648 109,991 105,132 109,991 Market capitalization1,8 113,036 105,173 105,719 101,903 113,036 101,903 Total book value per share (USD)1 28.17 27.35 26.80 26.13 28.17 26.13 Tangible book value per share (USD)1 25.95 25.18 24.63 23.85 25.95 23.85 Credit-impaired lending assets as a percentage of total lending assets, gross (%)3 0.9 1.0 1.0 0.9 0.9 0.9 Cost of credit risk (bps)3 10 7 15 6 8 6 1 Refer to the "Share information and earnings per share" section of the UBS Group second quarter 2025 report, available under "Quarterly reporting" at for more information. 2 Refer to the "Targets, capital guidance and ambitions" section of the UBS Group Annual Report 2024, available under "Annual reporting" at and to the "Recent development" section of the UBS Group second quarter 2025 report, available under "Quarterly reporting" at for more information about our performance targets. 3 Refer to "Alternative performance measures" in the appendix to the UBS Group second quarter 2025 report, available under "Quarterly reporting" at for the relevant definition(s) and calculation method(s). 4 Refer to the "Group performance" section of the UBS Group second quarter 2025 report, available under "Quarterly reporting" at for more information about underlying results. 5 Based on the Swiss systemically relevant bank framework. Refer to the "Capital management" section of the UBS Group second quarter 2025 report, available under "Quarterly reporting" at for more information. 6 The disclosed ratios represent quarterly averages for the quarters presented and are calculated based on an average of 61 data points in the second quarter of 2025, 62 data points in the first quarter of 2025, 64 data points in the fourth quarter of 2024 and 61 data points in the second quarter of 2024. Refer to the "Liquidity and funding management" section of the UBS Group second quarter 2025 report, available under "Quarterly reporting" at for more information. 7 Consists of invested assets for Global Wealth Management, Asset Management (including invested assets from associates) and Personal & Corporate Banking. Refer to "Note 31 Invested assets and net new money" in the "Consolidated financial statements" section of the UBS Group Annual Report 2024, available under "Annual reporting" at for more information. 8 The calculation of market capitalization reflects total shares issued multiplied by the share price at the end of the period. Income statement For the quarter ended % change from Year-to-date USD m 30.6.25 31.3.25 30.6.24 1Q25 2Q24 30.6.25 30.6.24 Net interest income 1,965 1,629 1,535 21 28 3,595 3,475 Other net income from financial instruments measured at fair value through profit or loss 3,408 3,937 3,684 (13) (7) 7,346 7,866 Net fee and commission income 6,708 6,777 6,531 (1) 3 13,485 13,023 Other income 30 213 154 (86) (80) 243 278 Total revenues 12,112 12,557 11,904 (4) 2 24,668 24,642 Credit loss expense / (release) 163 100 95 63 72 263 201 Personnel expenses 6,976 7,032 7,119 (1) (2) 14,008 14,068 General and administrative expenses 1,881 2,431 2,318 (23) (19) 4,312 4,731 Depreciation, amortization and impairment of non-financial assets 898 861 903 4 (1) 1,759 1,798 Operating expenses 9,756 10,324 10,340 (6) (6) 20,080 20,597 Operating profit / (loss) before tax 2,193 2,132 1,469 3 49 4,325 3,844 Tax expense / (benefit) (209) 430 293 221 905 Net profit / (loss) 2,402 1,702 1,175 41 104 4,105 2,939 Net profit / (loss) attributable to non-controlling interests 7 10 40 (30) (81) 18 48 Net profit / (loss) attributable to shareholders 2,395 1,692 1,136 42 111 4,087 2,890 Comprehensive income Total comprehensive income 5,357 3,345 1,614 60 232 8,703 1,369 Total comprehensive income attributable to non-controlling interests 22 26 18 (15) 21 48 13 Total comprehensive income attributable to shareholders 5,335 3,319 1,596 61 234 8,655 1,356 Information about results materials and the earnings call UBS's second quarter 2025 report, news release and slide presentation are available from 06:45 CEST on Wednesday, 30 July 2025, at UBS will hold a presentation of its second quarter 2025 results on Wednesday, 30 July 2025. The results will be presented by Sergio P. Ermotti (Group Chief Executive Officer), Todd Tuckner (Group Chief Financial Officer) and Sarah Mackey (Head of Investor Relations). Time09:00 CEST08:00 BST03:00 US EDT Audio webcastThe presentation for analysts can be followed live on with a simultaneous slide show. Webcast playbackAn audio playback of the results presentation will be made available at later in the day. Cautionary statement regarding forward-looking statements This news release contains statements that constitute "forward-looking statements", including but not limited to management's outlook for UBS's financial performance, statements relating to the anticipated effect of transactions and strategic initiatives on UBS's business and future development and goals or intentions to achieve climate, sustainability and other social objectives. While these forward-looking statements represent UBS's judgments, expectations and objectives concerning the matters described, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from UBS's expectations. In particular, the global economy may suffer significant adverse effects from increasing political tensions between world powers, changes to international trade policies, including those related to tariffs and trade barriers, and ongoing conflicts in the Middle East, as well as the continuing Russia–Ukraine war. UBS's acquisition of the Credit Suisse Group has materially changed its outlook and strategic direction and introduced new operational challenges. The integration of the Credit Suisse entities into the UBS structure is expected to continue through 2026 and presents significant operational and execution risk, including the risks that UBS may be unable to achieve the cost reductions and business benefits contemplated by the transaction, that it may incur higher costs to execute the integration of Credit Suisse and that the acquired business may have greater risks or liabilities than expected. Following the failure of Credit Suisse, Switzerland is considering significant changes to its capital, resolution and regulatory regime, which, if adopted, would significantly increase our capital requirements or impose other costs on UBS. These factors create greater uncertainty about forward-looking statements. Other factors that may affect UBS's performance and ability to achieve its plans, outlook and other objectives also include, but are not limited to: (i) the degree to which UBS is successful in the execution of its strategic plans, including its cost reduction and efficiency initiatives and its ability to manage its levels of risk-weighted assets (RWA) and leverage ratio denominator (LRD), liquidity coverage ratio and other financial resources, including changes in RWA assets and liabilities arising from higher market volatility and the size of the combined Group; (ii) the degree to which UBS is successful in implementing changes to its businesses to meet changing market, regulatory and other conditions; (iii) inflation and interest rate volatility in major markets; (iv) developments in the macroeconomic climate and in the markets in which UBS operates or to which it is exposed, including movements in securities prices or liquidity, credit spreads, currency exchange rates, residential and commercial real estate markets, general economic conditions, and changes to national trade policies on the financial position or creditworthiness of UBS's clients and counterparties, as well as on client sentiment and levels of activity; (v) changes in the availability of capital and funding, including any adverse changes in UBS's credit spreads and credit ratings of UBS, as well as availability and cost of funding to meet requirements for debt eligible for total loss-absorbing capacity (TLAC); (vi) changes in central bank policies or the implementation of financial legislation and regulation in Switzerland, the US, the UK, the EU and other financial centers that have imposed, or resulted in, or may do so in the future, more stringent or entity-specific capital, TLAC, leverage ratio, net stable funding ratio, liquidity and funding requirements, heightened operational resilience requirements, incremental tax requirements, additional levies, limitations on permitted activities, constraints on remuneration, constraints on transfers of capital and liquidity and sharing of operational costs across the Group or other measures, and the effect these will or would have on UBS's business activities; (vii) UBS's ability to successfully implement resolvability and related regulatory requirements and the potential need to make further changes to the legal structure or booking model of UBS in response to legal and regulatory requirements including heightened requirements and expectations due to its acquisition of the Credit Suisse Group; (viii) UBS's ability to maintain and improve its systems and controls for complying with sanctions in a timely manner and for the detection and prevention of money laundering to meet evolving regulatory requirements and expectations, in particular in the current geopolitical turmoil; (ix) the uncertainty arising from domestic stresses in certain major economies; (x) changes in UBS's competitive position, including whether differences in regulatory capital and other requirements among the major financial centers adversely affect UBS's ability to compete in certain lines of business; (xi) changes in the standards of conduct applicable to its businesses that may result from new regulations or new enforcement of existing standards, including measures to impose new and enhanced duties when interacting with customers and in the execution and handling of customer transactions; (xii) the liability to which UBS may be exposed, or possible constraints or sanctions that regulatory authorities might impose on UBS, due to litigation, contractual claims and regulatory investigations, including the potential for disqualification from certain businesses, potentially large fines or monetary penalties, or the loss of licenses or privileges as a result of regulatory or other governmental sanctions, as well as the effect that litigation, regulatory and similar matters have on the operational risk component of its RWA; (xiii) UBS's ability to retain and attract the employees necessary to generate revenues and to manage, support and control its businesses, which may be affected by competitive factors; (xiv) changes in accounting or tax standards or policies, and determinations or interpretations affecting the recognition of gain or loss, the valuation of goodwill, the recognition of deferred tax assets and other matters; (xv) UBS's ability to implement new technologies and business methods, including digital services, artificial intelligence and other technologies, and ability to successfully compete with both existing and new financial service providers, some of which may not be regulated to the same extent; (xvi) limitations on the effectiveness of UBS's internal processes for risk management, risk control, measurement and modeling, and of financial models generally; (xvii) the occurrence of operational failures, such as fraud, misconduct, unauthorized trading, financial crime, cyberattacks, data leakage and systems failures, the risk of which is increased with persistently high levels of cyberattack threats; (xviii) restrictions on the ability of UBS Group AG, UBS AG and regulated subsidiaries of UBS AG to make payments or distributions, including due to restrictions on the ability of its subsidiaries to make loans or distributions, directly or indirectly, or, in the case of financial difficulties, due to the exercise by FINMA or the regulators of UBS's operations in other countries of their broad statutory powers in relation to protective measures, restructuring and liquidation proceedings; (xix) the degree to which changes in regulation, capital or legal structure, financial results or other factors may affect UBS's ability to maintain its stated capital return objective; (xx) uncertainty over the scope of actions that may be required by UBS, governments and others for UBS to achieve goals relating to climate, environmental and social matters, as well as the evolving nature of underlying science and industry and the increasing divergence among regulatory regimes; (xxi) the ability of UBS to access capital markets; (xxii) the ability of UBS to successfully recover from a disaster or other business continuity problem due to a hurricane, flood, earthquake, terrorist attack, war, conflict, pandemic, security breach, cyberattack, power loss, telecommunications failure or other natural or man-made event; and (xxiii) the effect that these or other factors or unanticipated events, including media reports and speculations, may have on its reputation and the additional consequences that this may have on its business and performance. The sequence in which the factors above are presented is not indicative of their likelihood of occurrence or the potential magnitude of their consequences. UBS's business and financial performance could be affected by other factors identified in its past and future filings and reports, including those filed with the US Securities and Exchange Commission (the SEC). More detailed information about those factors is set forth in documents furnished by UBS and filings made by UBS with the SEC, including the UBS Group AG and UBS AG Annual Reports on Form 20-F for the year ended 31 December 2024. UBS is not under any obligation to (and expressly disclaims any obligation to) update or alter its forward-looking statements, whether as a result of new information, future events, or otherwise. Rounding Numbers presented throughout this news release may not add up precisely to the totals provided in the tables and text. Percentages and percent changes disclosed in text and tables are calculated on the basis of unrounded figures. Absolute changes between reporting periods disclosed in the text, which can be derived from numbers presented in related tables, are calculated on a rounded basis. Tables Within tables, blank fields generally indicate non-applicability or that presentation of any content would not be meaningful, or that information is not available as of the relevant date or for the relevant period. Zero values generally indicate that the respective figure is zero on an actual or rounded basis. Values that are zero on a rounded basis can be either negative or positive on an actual basis. Websites In this news release, any website addresses are provided solely for information and are not intended to be active links. UBS is not incorporating the contents of any such websites into this news release. View source version on Contacts UBS Group AG Investor contactSwitzerland: +41-44-234 41 00Americas: +1-212-882 57 34 Media contactSwitzerland: +41-44-234 85 00UK: +44-207-567 47 14Americas: +1-212-882 58 58APAC: +852-297-1 82 00 Sign in to access your portfolio